These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17250445)

  • 21. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting.
    Thompson B; Coronado G; Neuhouser M; Chen L
    Cancer; 2005 Jun; 103(12):2491-8. PubMed ID: 15880744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
    Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
    J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening.
    Ghai NR; Jensen CD; Corley DA; Doubeni CA; Schottinger JE; Zauber AG; Lee AT; Contreras R; Levin TR; Lee JK; Quinn VP
    Clin Transl Gastroenterol; 2018 Sep; 9(9):186. PubMed ID: 30242160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women.
    Tang TS; Solomon LJ; McCracken LM
    Cancer Pract; 2001; 9(6):277-82. PubMed ID: 11879329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
    Wu BU; Longstreth GF; Ngor EW
    Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer screening among African Americans: the importance of physician recommendation.
    Taylor V; Lessler D; Mertens K; Tu SP; Hart A; Chan N; Shu J; Thompson B
    J Natl Med Assoc; 2003 Sep; 95(9):806-12. PubMed ID: 14527047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group
    Med J Aust; 2006 Jun; 184(11):546-50. PubMed ID: 16768659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
    Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
    Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of colorectal cancer screening in a large medical organization.
    Hawley ST; Vernon SW; Levin B; Vallejo B
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):314-9. PubMed ID: 14973108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening preferences among African Americans: which screening test is preferred?
    Palmer RC; Midgette LA; Mullan ID
    J Cancer Educ; 2010 Dec; 25(4):577-81. PubMed ID: 20229075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Colorectal Cancer Knowledge and Screening Among Asian Americans Aged 50-75 years old.
    Juon HS; Guo J; Kim J; Lee S
    J Racial Ethn Health Disparities; 2018 Jun; 5(3):545-552. PubMed ID: 28664503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Chinese and Korean American immigrant experience: a mixed-methods examination of facilitators and barriers of colorectal cancer screening.
    Jung MY; Holt CL; Ng D; Sim HJ; Lu X; Le D; Juon HS; Li J; Lee S
    Ethn Health; 2018 Nov; 23(8):847-866. PubMed ID: 28277021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicians' use of nonphysician healthcare providers for colorectal cancer screening.
    Sansbury LB; Klabunde CN; Mysliwiec P; Brown ML
    Am J Prev Med; 2003 Oct; 25(3):179-86. PubMed ID: 14507523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.